Lv1
50 积分 2023-11-14 加入
Low-Dose Nivolumab Plus Brentuximab Vedotin As a Bridge to Stem Cell Transplantation in Relapsed/Refractory Classical Hodgkin Lymphoma
14天前
已关闭
Low-Dose Nivolumab Plus Brentuximab Vedotin As a Bridge to Stem Cell Transplantation in Relapsed/Refractory Classical Hodgkin Lymphoma
14天前
已关闭
The efficacy and safety of intravenous tocilizumab to treat Graves’ ophthalmopathy: A systematic review and single-arm meta-analysis
16天前
已关闭
Real World Efficacy of the Novel Chemo-Free Combination of Brentuximab Vedotin Plus Nivolumab (BvNivo) in Patients with Relapsed/Refractory Hodgkin Lymphoma. Single Center Experience
17天前
已关闭
Real World Efficacy of the Novel Chemo-Free Combination of Brentuximab Vedotin Plus Nivolumab (BvNivo) in Patients with Relapsed/Refractory Hodgkin Lymphoma. Single Center Experience
17天前
已关闭
Immunotherapy for older patients with classic Hodgkin lymphoma
17天前
已完结
Efficacy of Sacituzumab Govitecan in Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer
1个月前
已完结
Efficacy and safety of antibody–drug conjugates in the treatment of urothelial cell carcinoma: a systematic review and meta-analysis of prospective clinical trials
1个月前
已完结
Virtual reality gaming for rehabilitation of patients with urinary incontinence: A systematic review and meta‐analysis
1个月前
已完结
Minimally invasive posterior cervical foraminotomy versus the anterior transcorporeal approach for cervical radiculopathy: a systematic review and meta-analysis
1个月前
已完结
皖公网安备34019202002308
